TLR4 and esophageal cancer: For example, this study only conducted pharmacological experiments and did not conduct in vivo knockdown or overexpression bidirectional validation of the intervention effect of Ori on TLR4/NF-κB/NLRP3 in esophageal cancer mice, as well as its downstream effects.